News — Pacific 8 Ventures
Fauna Bio raises $9 Million to expand the comparative genomics platform for novel target discovery. This round is led by LifeForce Capital with participation from previous investors including Pacific 8 Ventures, True Ventures, and more.
Huge congratulations to Oguzhan, David, and the exceptional BillionToOne team on securing $130 million in an oversubscribed Series D funding round. This funding will further revolutionize the prenatal screening and oncology diagnostics landscape. Read More —> Read more → June 21, 2024 Mammoth and Regeneron will collaborate on in vivo CRISPR-based gene editing therapies in a deal worth $100 million upfront plus $370 million in milestones per target. Read More —> Read more → April 25, 2024 Fauna Bio improving human health by leveraging animal genomics, today announced a multi-year…
saved by
related reading
- Mission BioCapital collects $275m for fifth fundventurecapitaljournal.com
- TechCrunch | Startup and Technology Newstechcrunch.com
- The AI Services Wave: Lessons from Palantir in The New Age of AI | Posts | 8VC8vc.com
- Biotech Startups: Move Slow and Fix Things - Stanford Biotechnology Groupstanfordbiotechgroup.com
- Network Bio Q1 2023 Investor Update - by network.bionetworkbio.substack.com
- Fundraising for Founder-led Biotech – Matt Krisiloffmattkrisiloff.com
- List of Biotechnology Companies to Watch – AI Expanded Versionsubstack.com
- Benchmark raises its first-ever growth fund as part of $2B capital haul | TechCrunchtechcrunch.com
- Y Combinator wants 100 times more MRI scans | TechCrunchtechcrunch.com
- Curie.Biocurie.bio
- Voyager Ventures Launches $100M Fund I to Invest in Climate Tech Across North America and Europeprnewswire.com
- On AI Infrastructure in Biology - by Elliot Hershbergcenturyofbio.com